发明名称 Thia-triaza-indacenes
摘要 The present invention encompasses compounds of general formula (1) wherein R1 to R3 and X are defined as in claim 1, which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation, and the use thereof for preparing a medicament having the above-mentioned properties.;
申请公布号 US9243000(B2) 申请公布日期 2016.01.26
申请号 US201013265241 申请日期 2010.04.22
申请人 Boehringer Ingelheim International GmbH 发明人 Van Der Veen Lars;McConnell Darryl;Schneider Siegfried;Grauert Matthias;Schoop Andreas;Wunberg Tobias
分类号 C07D513/04;A61K31/381;C07D513/14 主分类号 C07D513/04
代理机构 代理人 Morris Michael P.;Stempel Alan R.
主权项 1. A compound selected from the group consisting of:No.MOLSTRUCTUREB1B2B3B4B5B6B7B8B9B10B11B12B13B14B15B16B17B18B19B20B21B22B23B24B25B26B27B28B29B30B31B32B33B34C1C2C3C4C5C6C7C8C9C10C11C12C13C14C15C16C17C18C19C20C21C22C23E-01E-02E-03E-04E-05E-06E-07E-08E-09E-10E-11E-12E-13E-14E-15E-16E-17E-18E-19E-20E-21E-22E-23E-24E-25E-26E-27E-28E-29E-30E-31E-32E-33E-34E-35E-36E-37E-38E-39E-40E-41E-42F-01F-02F-03F-04G-01G-02G-03G-04G-05G-06G-07G-08G-09 or a salt thereof.
地址 Ingelheim am Rhein DE